Analysts predict the global ASC market will reach $93.46 billion by 2025, according to Hexa Research insights published on newKerala.com.
Five takeaways:
1. The gastroenterology segment of the market is expected to be the fastest-growing segment, with a compound annual growth rate of more than 6.5 percent from 2017 to 2025.
2. In 2017, North America comprised 47 percent of the global ASC market. Analysts expect the Asia Pacific region to be the fastest-growing region, due to its large population and rise in chronic diseases.
3. Analysts have seen increased government spending in the ASC market as an effort to reduce healthcare costs and increase accessibility.
4. Growing prevalence of cardiovascular disease, cataracts, chronic pulmonary disorder and stroke contributes to the positive growth prospect of ASCs.
5. The key value proposition for ASCs will be the inclusion of accessible diagnostics, along with quality surgeons and staff members.
More articles on turnarounds:
CalvertHealth clinicians join North American Partners in Anesthesia — 3 insights
Leadership training & anonymous reporting in anesthesia — 3 key insights
Colorado anesthesiologist's license suspended after allegedly obtaining opioids illegally — 4 insights